Biotech

masquerade mask
Biotech

Third Arc Bio teams up with Adagene to create T-cell engagers

Third Arc Bio is paying $5 million upfront to use Adagene’s tech in hopes of creating two new masked T-cell engagers.
Gabrielle Masson Nov 13, 2025 10:45am
pipelines in the sun

Century, Candel, MacroGenics call time on trials to save cash

Nov 13, 2025 10:15am
Syneos Health executive highlights innovation collaboration in clinical trials

Syneos Health executive highlights innovation, collaboration in clinical trials

Nov 11, 2025 8:00am
Illustration connected puzzle pieces with the acronym MA

Day One pens $285M deal for Mersana

Nov 13, 2025 10:15am
Medicus Pharma Advances Newly Acquired Program Teverelix in Prostate Cancer and Urology

Medicus pharma advances Teverelix in prostate cancer and urology

Nov 10, 2025 8:00am
yellow traffic light

Zealand pumps brakes on development of dual GLP-1/GLP-2 agonist

Nov 13, 2025 9:52am